Sodium Bicarbonate Injection

In the fast-paced world of critical care medicine, having reliable and effective treatments can make all the difference between life and death. Sodium Bicarbonate Injection 8.4% (SODA-Q100) stands out as a cornerstone therapy for managing metabolic acidosis and other emergency conditions. Produced by J-BANS ICU Care, a leading name in injectable pharmaceuticals, this product exemplifies innovation and quality in ICU settings. Whether you’re a healthcare professional, distributor, or entrepreneur exploring opportunities in pharma, understanding SODA-Q100’s role is essential. J-BANS ICU Care has built its reputation on delivering life-saving medicines that meet global standards. As you explore our offerings on you’ll see a commitment to affordable, high-quality critical care solutions. This injection is part of their extensive range designed for intensive care units, where rapid intervention is crucial. What is Sodium Bicarbonate Injection 8.4%? Sodium Bicarbonate Injection IP (8.4% w/v) is a sterile, hypertonic solution used primarily as an alkalizing agent. It contains sodium bicarbonate as the active ingredient, which helps restore acid-base balance in the body. Marketed under the brand name SODA-Q100, this 100 ml vial is specifically formulated for intravenous (I.V.) infusion. The product’s packaging features a clear label with essential details: “Sodium Bicarbonate Injection IP (8.4% w/v)” and “For I.V. Infusion.” The vial is designed for easy handling in high-pressure environments like ICUs, ensuring quick access during emergencies. This formulation is particularly potent, with each milliliter providing 1 mEq of sodium and bicarbonate ions. It’s preserved in a glass bottle to maintain stability and purity, reducing the risk of contamination

Click to Visit Site